ArticleFrontiers in oncology2023

Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC).

Margaret F Meagher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.